Covered recipient · General Payments record
HUSAM FARIS GHUSN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2024–2025
$470.47
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $388.54 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $203.01 | 4 |
| Amgen Inc. | $124.97 | 1 |
| Insulet Corporation | $23.14 | 1 |
| Ascendis Pharma Endocrinology Inc | $20.33 | 1 |
| Corcept Therapeutics | $17.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $124.97 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228421807 | CMS |
| Ascendis Pharma Endocrinology Inc | $20.33 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237051592 | CMS |
| Corcept Therapeutics | $17.09 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214241768 | CMS |
| Insulet Corporation | $23.14 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207139812 | CMS |
| Novo Nordisk Inc | $11.18 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189085812 | CMS |
| Novo Nordisk Inc | $49.99 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188241061 | CMS |
| Novo Nordisk Inc | $56.48 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188939746 | CMS |
| Novo Nordisk Inc | $85.36 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188400176 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.